BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26252164)

  • 1. FOXD3 Promotes PAX3 Expression in Melanoma Cells.
    Kubic JD; Little EC; Kaiser RS; Young KP; Lang D
    J Cell Biochem; 2016 Feb; 117(2):533-41. PubMed ID: 26252164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAX3 and FOXD3 Promote CXCR4 Expression in Melanoma.
    Kubic JD; Lui JW; Little EC; Ludvik AE; Konda S; Salgia R; Aplin AE; Lang D
    J Biol Chem; 2015 Sep; 290(36):21901-14. PubMed ID: 26205821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FOXD3 regulates the lineage switch between neural crest-derived glial cells and pigment cells by repressing MITF through a non-canonical mechanism.
    Thomas AJ; Erickson CA
    Development; 2009 Jun; 136(11):1849-58. PubMed ID: 19403660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Foxd3 mediates zebrafish myf5 expression during early somitogenesis.
    Lee HC; Huang HY; Lin CY; Chen YH; Tsai HJ
    Dev Biol; 2006 Feb; 290(2):359-72. PubMed ID: 16386728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoid enhancer factor-1 mediates loading of Pax3 to a promoter harbouring lymphoid enhancer factor-1 binding sites resulting in enhancement of transcription.
    Christova T; Mojtahedi G; Hamel PA
    Int J Biochem Cell Biol; 2010 May; 42(5):630-40. PubMed ID: 20006729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional interaction between Foxd3 and Pax3 in cardiac neural crest development.
    Nelms BL; Pfaltzgraff ER; Labosky PA
    Genesis; 2011 Jan; 49(1):10-23. PubMed ID: 21254333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pax3 regulates Wnt1 expression via a conserved binding site in the 5' proximal promoter.
    Fenby BT; Fotaki V; Mason JO
    Biochim Biophys Acta; 2008 Feb; 1779(2):115-21. PubMed ID: 18086577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The winged-helix transcription factor Foxd3 suppresses interneuron differentiation and promotes neural crest cell fate.
    Dottori M; Gross MK; Labosky P; Goulding M
    Development; 2001 Nov; 128(21):4127-38. PubMed ID: 11684651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAX3 knockdown in metastatic melanoma cell lines does not reduce MITF expression.
    He S; Li CG; Slobbe L; Glover A; Marshall E; Baguley BC; Eccles MR
    Melanoma Res; 2011 Feb; 21(1):24-34. PubMed ID: 21164369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAX3 across the spectrum: from melanoblast to melanoma.
    Medic S; Ziman M
    Crit Rev Biochem Mol Biol; 2009 Jun; 44(2-3):85-97. PubMed ID: 19401874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alveolar rhabdomyosarcoma PAX3/FKHR fusion protein is a transcriptional activator.
    Sublett JE; Jeon IS; Shapiro DN
    Oncogene; 1995 Aug; 11(3):545-52. PubMed ID: 7630639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PAX3 and ETS1 synergistically activate MET expression in melanoma cells.
    Kubic JD; Little EC; Lui JW; Iizuka T; Lang D
    Oncogene; 2015 Sep; 34(38):4964-74. PubMed ID: 25531327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional regulation by Pax3 and TGFbeta2 signaling: a potential gene regulatory network in neural crest development.
    Nakazaki H; Shen YW; Yun B; Reddy A; Khanna V; Mania-Farnell B; Ichi S; McLone DG; Tomita T; Mayanil CS
    Int J Dev Biol; 2009; 53(1):69-79. PubMed ID: 19123128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pax3 and Zic1 trigger the early neural crest gene regulatory network by the direct activation of multiple key neural crest specifiers.
    Plouhinec JL; Roche DD; Pegoraro C; Figueiredo AL; Maczkowiak F; Brunet LJ; Milet C; Vert JP; Pollet N; Harland RM; Monsoro-Burq AH
    Dev Biol; 2014 Feb; 386(2):461-72. PubMed ID: 24360906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of transcription factors and their possible roles in the regulation of Pax3 gene expression in the mouse B16 F1 melanoma cell line.
    Zhu BK; Pruitt SC
    Melanoma Res; 2005 Oct; 15(5):363-73. PubMed ID: 16179863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of minimal enhancer elements sufficient for Pax3 expression in neural crest and implication of Tead2 as a regulator of Pax3.
    Milewski RC; Chi NC; Li J; Brown C; Lu MM; Epstein JA
    Development; 2004 Feb; 131(4):829-37. PubMed ID: 14736747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of target genes of PAX3-FOXO1 in alveolar rhabdomyosarcoma.
    Ahn EH
    Anticancer Res; 2013 May; 33(5):2029-35. PubMed ID: 23645752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hox/Pbx and Brn binding sites mediate Pax3 expression in vitro and in vivo.
    Pruitt SC; Bussman A; Maslov AY; Natoli TA; Heinaman R
    Gene Expr Patterns; 2004 Oct; 4(6):671-85. PubMed ID: 15465489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAX3 and SOX10 activate MET receptor expression in melanoma.
    Mascarenhas JB; Littlejohn EL; Wolsky RJ; Young KP; Nelson M; Salgia R; Lang D
    Pigment Cell Melanoma Res; 2010 Apr; 23(2):225-37. PubMed ID: 20067553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phosphatidylinositol 3-kinase-Pax3 axis regulates Brn-2 expression in melanoma.
    Bonvin E; Falletta P; Shaw H; Delmas V; Goding CR
    Mol Cell Biol; 2012 Nov; 32(22):4674-83. PubMed ID: 22988297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.